Related Experiment Videos
Options for percutaneous coronary and peripheral revascularization
Insights
Balloon angioplasty remains a key treatment for atherosclerosis. New devices may enhance percutaneous interventions, but further trials are needed to confirm their clinical utility and long-term success.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Angioplasty is a standard treatment for coronary and peripheral atherosclerosis.
- Percutaneous interventions are evolving with new techniques and devices.
Purpose of the Study:
- To review the current status and future prospects of angioplasty.
- To highlight the potential of new devices in improving angioplasty outcomes.
Main Methods:
- Review of established and emerging angioplasty techniques.
- Discussion of the role of new devices in percutaneous interventions.
Main Results:
- Balloon angioplasty is expected to remain the primary percutaneous treatment.
- New devices hold promise for expanding angioplasty's role and improving long-term success.
Conclusions:
- Continued innovation in devices is anticipated to enhance angioplasty.
- Prospective randomized trials are essential to evaluate the clinical utility of new procedures and devices.
Abstract:
Angioplasty has become an established treatment for both coronary and peripheral atherosclerosis, and a number of new techniques and devices promise to improve the results of percutaneous intervention during the coming decades. It is likely that balloon angioplasty will remain the percutaneous treatment of choice for both coronary and peripheral intervention; however, we look with hope toward the development of new devices that will expand the role of percutaneous angioplasty and improve the long-term success of these procedures. As technical expertise grows with the new procedures, prospective randomized trials comparing them with standard PTCA will be required to enable physicians to judge their clinical utility.